NeonMind Biosciences Inc.
OTC: NMDBF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Penny Olga White BA, LLB
- Headquarters
- Oakville, Canada
- IPO year
- 2021
- Market cap
- $8.5K
- Website
- https://www.neonmindbiosciences.com
Loading NMDBF…
Loading profile data…Frequently asked questions about NMDBF
What does NeonMind Biosciences Inc. (NMDBF) do?
NeonMind Biosciences Inc. specializes in the research, formulation, and commercialization of medicinal and psychedelic fungi aimed at treating mental health conditions. The company is actively developing a line of psilocybin-derived products, featuring various mushroom-infused preparations, specifically tailored for weight loss and management. O...
Where does NMDBF trade?
NeonMind Biosciences Inc. (NMDBF) trades on the Other OTC.
What sector is NMDBF in?
NeonMind Biosciences Inc. (NMDBF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NeonMind Biosciences Inc.?
Penny Olga White BA, LLB is the chief executive officer of NeonMind Biosciences Inc. (NMDBF).
Where is NeonMind Biosciences Inc. headquartered?
NeonMind Biosciences Inc. is headquartered in Canada.
Does NMDBF pay a dividend?
NeonMind Biosciences Inc. (NMDBF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NMDBF go public?
NeonMind Biosciences Inc. (NMDBF) completed its initial public offering in 2021.